ausblenden:
Schlagwörter:
INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS;
NECROSIS-FACTOR-ALPHA; IL-8 RECEPTOR; NEUTROPHIL MIGRATION; CHEMOKINE
EXPRESSION; MONOCLONAL-ANTIBODY; MURINE COLITIS; CROHNS-DISEASE; IN-VIVOCell Biology; Hematology; Immunology; rodent; neutrophils; inflammation;
Zusammenfassung:
Polymorphonuclear leukocyte infiltration and activation into colonic mucosa are believed to play a pivotal role in mediating tissue damage in human ulcerative colitis (UC). Ligands of human CXC chemokine receptor I and 2 (CXCR1/R2) are chemoattractants of PAIN, and high levels were found in the mucosa of UC patients. To investigate the pathophysiological role played by CXCR2 in experimental UC, we induced chronic experimental colitis in WT and CXCR2(-/-) mice by two consecutive cycles of 4% dextran sulfate sodium administration in drinking water. In wild-type (WT) mice, the chronic relapsing of DSS-induced colitis was characterized by clinical signs and histopathological findings that closely resemble human disease. CXCR2-/- mice failed to show PMN infiltration into the mucosa and, consistently with a key role of PAIN in mediating tissue damage in UC, showed limited signs of mucosal damage and reduced clinical symptoms. Our data demonstrate that CXCR2 plays a key pathophysiological role in experimental UC, suggesting that CXCR2 activation may represent a relevant pharmacological target for the design of novel pharmacological treatments in human UC.
